Protocol Summaries: GSK1059615
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| PIK111051 | Phase 1 | A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK1059615 in Patients with Solid Tumors or Lymphoma | Terminated |
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| PIK111051 | Phase 1 | A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK1059615 in Patients with Solid Tumors or Lymphoma | Terminated |